Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 31,480 | 26,131 | 26,812 | 27,613 | 26,379 |
| Operating Income | -31,480 | -26,131 | -26,812 | -27,613 | -26,379 |
| Interest Expense | 7 | 16 | 1 | 16 | 7 |
| Other Income | 15 | 22 | 2 | 10 | 10 |
| Pre-tax Income | -31,472 | -26,125 | -26,811 | -27,619 | -26,376 |
| Net Income Continuous | -31,472 | -26,125 | -26,811 | -27,619 | -26,376 |
| Net Income | $-31,472 | $-26,125 | $-26,811 | $-27,619 | $-26,376 |
| EPS Basic Total Ops | -17.92 | -14.40 | -15.36 | -17.76 | -17.28 |
| EPS Basic Continuous Ops | -18.00 | -14.63 | -15.34 | -17.70 | -17.21 |
| EPS Diluted Total Ops | -17.92 | -14.40 | -15.36 | -17.76 | -17.28 |
| EPS Diluted Continuous Ops | -18.00 | -14.63 | -15.34 | -17.70 | -17.21 |
| EBITDA(a) | $-31,403 | $-26,055 | $-26,735 | $-27,534 | $-26,314 |